Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 30, 2017

View Archived Issues

Celgene offers product and pipeline update for third quarter 2017

Bristol-Myers Squibb offers product and pipeline update from third quarter 2017

Mitobridge describes novel PPAR-delta agonists

JCR Pharmaceuticals to initiate development of JR-171 for Hurler Syndrome

Allergan presents new fMet-Leu-Phe receptor modulators

Boehringer Ingelheim discovers new orexin receptor type 1 antagonists

Novel proto-oncogene c-Ret inhibitors identified at Cancer Research Technology

DS-5010 demonstrates potent antitumor activity in vitro and in vivo

New antibacterials patented by Actelion Pharmaceuticals

FDA grants priority review to elagolix for endometriosis-associated pain

Successful tumor imagining with novel somatostatin receptor antagonist 68Ga-NODAGA-LM3

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Phase I trial to evaluate Curevac's immunomodulator CV-8102

Sumitomo Dainippon and Poxel sign strategic partnership for imeglimin in Asias countries

Merck & Co. withdraws European application for Keytruda in first-line metastatic non-squamous NSCLC

Novartis proposes to acquire Advanced Accelerator Applications

Argenx initiates phase I trial of subcutaneous formulation of ARGX-113

Clinical data for maralixibat in patients with Alagille syndrome presented

Janssen conducts phase 0 exploratory trial of [18F]MNI-1020 as imaging marker for tau protein

Reversible 18F-labeled tracer GEH200431-B a potential candidate for MAO-B imaging in humans

Rgenix releases preliminary phase Ia/b data on RGX-104 in advanced cancer

[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer

Longevity Biotech awarded grant to evaluate LBT-3627 for multiple sclerosis

New phase I study at Stanford explores CD19/CD22-CAR T cells for B-cell malignancies

Mereo agrees with AstraZeneca on exclusive license and option to acquire AZD-9668

New ATOM consortium aims to reduce preclinical cancer drug discovery time

Astellas establishes screening collaboration agreement with MMV for malaria

Daiichi Sankyo and Glycotope sign option agreement on ADC collaboration and licensing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...